Corcept Therapeutics Incorporated Class Action Lawsuit
Company: Corcept Therapeutics Incorporated
Ticker: (NASDAQ) CORT
Class Action Period: October 31, 2024 - December 30, 2025
See If You Qualify For Monetary Reward
Join the Corcept Therapeutics Incorporated Class Action Lawsuit
CLASS ACTION PERIOD
October 31, 2024 - December 30, 2025
Allegations
According to the filed complaint, defendants made false statements and/or concealed that: In light of the circumstances in which they were made, not false and misleading. In truth, the FDA had told Corcept that it had concerns about the adequacy of the program assessing relacorilant’s effectiveness in treating hypertension in patients with hypercortisolism, including the design of the GRACE study. The FDA had further told Corcept to expect significant issues with the review if Corcept was to submit the NDA. As a result, Defendants’ positive statements concerning their interactions with the FDA and their expectations that the relacorilant NDA would be approved, were materially false or misleading.
Eligibility
To join the lawsuit, you must have experienced a loss on Corcept Therapeutics Incorporated shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Corcept Therapeutics Incorporated during the relevant time frame, you have until April 21, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
EXPLORE MORE CASES
Varonis Systems, Inc.
VRNS
Lead Plaintiff Deadline: March 9, 2026
Class Period: February 4, 2025 - October 28, 2025
Ramaco Resources, Inc.
METC
Lead Plaintiff Deadline: March 31, 2026
Class Period: July 31, 2025 - October 23, 2025